Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs
- PMID: 33009167
- DOI: 10.1097/ADM.0000000000000753
Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs
Abstract
: Globally, there are concerns about access to healthcare and harm reduction services for people who use drugs (PWUD) during the coronavirus disease 2019 (COVID-19) pandemic. Members from the Network of Early Career Professionals working in Addiction Medicine shared their experiences of providing treatment to PWUD during the COVID-19 pandemic. Drawing on these qualitative reports, we highlight the similarities and discrepancies in access to services for PWUD in 16 countries under COVID-10 restrictions. In most countries reported here, efforts have been made to ensure continued access to services, such as mobilising opioid agonist maintenance treatment and other essential medicines to patients. However, due to travel restrictions and limited telemedicine services, several Network of Early Career Professionals working in Addiction Medicine members from lower-resourced countries experienced challenges with providing care to their patients during periods of COVID-19 lock-down. The insights provided in this commentary illustrate how the COVID-19 lock-down restrictions have impacted access to services for PWUD.
References
-
- International standards for the treatment of drug use disorders: revised edition incorporating results of field-testing. Geneva (2020). World Health Organization and United Nations Office on Drugs and Crime.
-
- Suggestions about treatment, care and rehabilitation of people with drug use disorder in the context of the COVID-19 pandemic. (2020). United Nations Office on Drugs and Crime. Available at: https://www.unodc.org/ropan/en/suggestions-about-treatment--care-and-reh... Accessed June 7, 2020.
-
- Dunlop A, Lokuge B, Masters D, et al. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduct J 2020; 17:1–7.
-
- Farhoudian A, Baldacchino A, Clark N, et al. COVID-19 and substance use disorders: recommendations to a comprehensive healthcare response. An international society of addiction medicine (ISAM) practice and policy interest group position paper. Auton Neurosci Basic Clin 2020; 11 (2):129–146.
-
- Zhou X, Snoswell CL, Harding LE, et al. The role of telehealth in reducing the mental health burden from COVID-19. Telemed e-Health 2020; 26 (4):377–379.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical